Q3 Earnings Forecast for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK - Free Report) - Analysts at Leerink Partnrs boosted their Q3 2025 earnings per share estimates for shares of McKesson in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $8.87 for the quarter, up from their previous estimate of $8.54. The consensus estimate for McKesson's current full-year earnings is $31.92 per share. Leerink Partnrs also issued estimates for McKesson's Q4 2025 earnings at $9.11 EPS, FY2025 earnings at $32.90 EPS and FY2028 earnings at $47.45 EPS.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.89 by $0.18. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The company had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the prior year, the company earned $6.23 earnings per share. The company's revenue for the quarter was up 21.3% compared to the same quarter last year.

Several other equities research analysts also recently issued reports on the stock. Mizuho increased their price objective on shares of McKesson from $540.00 to $570.00 and gave the stock a "neutral" rating in a research report on Thursday, August 8th. Citigroup dropped their price target on McKesson from $670.00 to $630.00 and set a "buy" rating on the stock in a research note on Tuesday, September 10th. Evercore ISI boosted their price target on McKesson from $560.00 to $680.00 and gave the company an "outperform" rating in a report on Thursday. Leerink Partners decreased their price objective on McKesson from $665.00 to $630.00 and set an "outperform" rating for the company in a report on Monday, October 7th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a research note on Wednesday, September 25th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $625.64.

McKesson Stock Performance

MCK stock traded up $5.61 during mid-day trading on Friday, hitting $613.12. 1,270,489 shares of the company were exchanged, compared to its average volume of 822,390. McKesson has a 1-year low of $431.35 and a 1-year high of $637.51. The firm's 50 day simple moving average is $513.03 and its 200 day simple moving average is $551.60. The firm has a market cap of $79.51 billion, a P/E ratio of 27.42, a P/E/G ratio of 1.23 and a beta of 0.44.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.46%. McKesson's dividend payout ratio is presently 12.70%.

Insider Activity

In related news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the completion of the transaction, the chief executive officer now owns 78,586 shares in the company, valued at approximately $44,094,604.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.11% of the stock is owned by insiders.

Institutional Investors Weigh In On McKesson

Hedge funds have recently added to or reduced their stakes in the business. LRI Investments LLC bought a new position in shares of McKesson in the first quarter valued at about $28,000. MidAtlantic Capital Management Inc. acquired a new stake in McKesson during the third quarter worth approximately $29,000. Wolff Wiese Magana LLC grew its position in shares of McKesson by 742.9% in the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company's stock valued at $29,000 after purchasing an additional 52 shares during the last quarter. ORG Wealth Partners LLC acquired a new stake in McKesson during the 3rd quarter worth approximately $40,000. Finally, Carmichael Hill & Associates Inc. bought a new stake in McKesson in the 2nd quarter valued at $52,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.